Literature DB >> 4208508

Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis.

G L Hobby, A P Holman, M D Iseman, J M Jones.   

Abstract

A method for precise microscopic enumeration of acid-fast bacilli in the sputum of patients with pulmonary tuberculosis is described. The total number of acid-fast bacilli and the number of culturable cell units of tubercle bacilli per milliliter of sputum were determined in 269 specimens from 28 patients collected prior to and/or during chemotherapy, to establish the usefulness of the procedure for evaluation of the effects of chemotherapy. Prior to or very early in the course of therapy, there was good agreement between microscopically and culturally measurable bacilli in 27 of 28 patients. Thereafter, there were systematic divergences in five patients and occasional divergences in most others. Yet, in general, in 20 of the 28 patients, the microscopically determined population provided a useful measure of the number of culturable tubercle bacilli present. Although the microscopic procedure does not allow species identification of mycobacteria or differentiation between viable and nonviable cells, it often provided, within hours rather than days or weeks, useful information on the residual burden of acid-fast bacilli in sputum during chemotherapy. The nature of the disease in those patients in whom microscopy failed to provide useful information is discussed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4208508      PMCID: PMC444512          DOI: 10.1128/AAC.4.2.94

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  STUDIES ON MYCOBACTERIUM TUBERCULOSIS IN LESIONS OF THE HUMAN LUNG. A NEW METHOD OF STAINING TUBERCLE BACILLI IN TISSUE SECTIONS.

Authors:  W NYKA
Journal:  Am Rev Respir Dis       Date:  1963-11

2.  Cytochemical studies on the differentiation of living and dead acid-fast bacilli.

Authors:  T MUROHASHI; K YOSHIDA
Journal:  Acta Tuberc Scand       Date:  1957

3.  The appearance of dead leprosy bacilli by light and electron microscopy.

Authors:  R J REES; R C VALENTINE
Journal:  Int J Lepr       Date:  1962 Jan-Mar

4.  Comparison of various staining methods for demonstration of tubercle bacilli in suputum by direct microscopy.

Authors:  H C Engbaek; J Bennedsen; S Olesen Larsen
Journal:  Bull Int Union Tuberc       Date:  1969-08

Review 5.  Microbial persistence.

Authors:  W McDermott
Journal:  Harvey Lect       Date:  1969

6.  Quantitative studies of mycobacterial populations in sputum and saliva.

Authors:  H Yeager; J Lacy; L R Smith; C A LeMaistre
Journal:  Am Rev Respir Dis       Date:  1967-06

7.  Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae.

Authors:  R J Rees
Journal:  Nature       Date:  1966-08-06       Impact factor: 49.962

8.  Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis.

Authors:  K Takayama; L Wang; H L David
Journal:  Antimicrob Agents Chemother       Date:  1972-07       Impact factor: 5.191

9.  Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis.

Authors:  L Wang; K Takayama
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

10.  Microbial persistence.

Authors:  W McDERMOTT
Journal:  Yale J Biol Med       Date:  1958-02
View more
  46 in total

1.  A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.

Authors: 
Journal:  Pneumonologie       Date:  1975-12-12

2.  Improved sensitivity of sputum smear microscopy after processing specimens with C18-carboxypropylbetaine to detect acid-fast bacilli: a study of United States-bound immigrants from Vietnam.

Authors:  K F Laserson; N T N Yen; C G Thornton; V T C Mai; W Jones; D Q An; N H Phuoc; N A Trinh; D T C Nhung; T X Lien; N T N Lan; C Wells; N Binkin; M Cetron; S A Maloney
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Autofluorescence of mycobacteria as a tool for detection of Mycobacterium tuberculosis.

Authors:  Sol Patiño; Lorenzo Alamo; Mena Cimino; Yveth Casart; Fulvia Bartoli; María J García; Leiria Salazar
Journal:  J Clin Microbiol       Date:  2008-10       Impact factor: 5.948

4.  Modeling and Simulation of Pretomanid Pharmacodynamics in Pulmonary Tuberculosis Patients.

Authors:  Michael A Lyons
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

5.  Smear results in the diagnosis of mycobacterioses using blue light fluorescence microscopy.

Authors:  H M Pollock; E J Wieman
Journal:  J Clin Microbiol       Date:  1977-03       Impact factor: 5.948

6.  Application of the C(18)-carboxypropylbetaine specimen processing method to recovery of Mycobacterium avium subsp. paratuberculosis from ruminant tissue specimens.

Authors:  Charles G Thornton; Kerry M MacLellan; Judith R Stabel; Christine Carothers; Robert H Whitlock; Selvin Passen
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

7.  Reporter enzyme fluorescence (REF) imaging and quantification of tuberculosis in live animals.

Authors:  Ying Kong; Jeffrey D Cirillo
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

8.  Amplification of rRNA for assessment of treatment response of pulmonary tuberculosis patients during antimicrobial therapy.

Authors:  D F Moore; J I Curry; C A Knott; V Jonas
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

9.  A new unifying theory of the pathogenesis of tuberculosis.

Authors:  Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2013-08-04       Impact factor: 3.131

Review 10.  Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.

Authors:  ShuQi Wang; Fatih Inci; Gennaro De Libero; Amit Singhal; Utkan Demirci
Journal:  Biotechnol Adv       Date:  2013-01-26       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.